AUG 17, 2026 · PHASE 3 TRIAL
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcomes have not yet been assessed or reported.
Reported
Planned enrollment1410
PhasePHASE 3
Primary outcome: Overall Survival…Approximately 39 months